Gokengin D[au] - Search Results

Year	Number of Results
2002	1
2003	2
2004	2
2005	1
2007	1
2012	1
2013	1
2014	4
2015	1
2016	6
2017	3
2018	2
2019	1
2020	7
2021	10
2022	9
2023	1

1

SARS-CoV-2 epidemiology and control, different scenarios for Turkey.

Petersen E, Gökengin D. Petersen E, et al. Among authors: gokengin d. Turk J Med Sci. 2020 Apr 21;50(SI-1):509-514. doi: 10.3906/sag-2003-260. Turk J Med Sci. 2020. PMID: 32283894 Free PMC article. Review.

2

Sexual transmission of infections across Europe: appraising the present, scoping the future.

Geretti AM, Mardh O, de Vries HJC, Winter A, McSorley J, Seguy N, Vuylsteke B, Gokengin D. Geretti AM, et al. Among authors: gokengin d. Sex Transm Infect. 2022 May 10:sextrans-2022-055455. doi: 10.1136/sextrans-2022-055455. Online ahead of print. Sex Transm Infect. 2022. PMID: 35537800 Review.

3

HIV/AIDS: trends in the Middle East and North Africa region.

Gökengin D, Doroudi F, Tohme J, Collins B, Madani N. Gökengin D, et al. Int J Infect Dis. 2016 Mar;44:66-73. doi: 10.1016/j.ijid.2015.11.008. Int J Infect Dis. 2016. PMID: 26948920 Free article. Review.

4

2021 European guideline on HIV testing in genito-urinary medicine settings.

Gökengin D, Wilson-Davies E, Nazlı Zeka A, Palfreeman A, Begovac J, Dedes N, Tarashenko O, Stevanovic M, Patel R. Gökengin D, et al. J Eur Acad Dermatol Venereol. 2021 May;35(5):1043-1057. doi: 10.1111/jdv.17139. Epub 2021 Mar 5. J Eur Acad Dermatol Venereol. 2021. PMID: 33666276

5

Favipiravir for the treatment of COVID-19 pneumonia: Can we predict the response to treatment?

Sayiner A, Erdem HA, Korkmaz Ekren P, Tasbakan S, Basoglu OK, Tasbakan MI, Yamazhan T, Gokengin D, Ozhan MH. Sayiner A, et al. Among authors: gokengin d. J Infect Dev Ctries. 2022 Mar 31;16(3):422-426. doi: 10.3855/jidc.14033. J Infect Dev Ctries. 2022. PMID: 35404846 Free article.

6

HIV‑1 molecular epidemiology in the Balkans: a melting pot for high genetic diversity.

Stanojevic M, Alexiev I, Beshkov D, Gökengin D, Mezei M, Minarovits J, Otelea D, Paraschiv S, Poljak M, Zidovec-Lepej S, Paraskevis D. Stanojevic M, et al. Among authors: gokengin d. AIDS Rev. 2012 Jan-Mar;14(1):28-36. AIDS Rev. 2012. PMID: 22297502 Review.

7

One and a half years into the COVID-19 pandemic - exit strategies and efficacy of SARS-CoV-2 vaccines for holistic management and achieving global control.

Petersen E, Gökengin D, Al Balushi A, Zumla A. Petersen E, et al. Among authors: gokengin d. Turk J Med Sci. 2021 Dec 17;51(SI-1):3157-3161. doi: 10.3906/sag-2106-236. Turk J Med Sci. 2021. PMID: 34284531 Free PMC article. Review.

8

2014 European Guideline on HIV testing.

Gökengin D, Geretti AM, Begovac J, Palfreeman A, Stevanovic M, Tarasenko O, Radcliffe K. Gökengin D, et al. Int J STD AIDS. 2014 Sep;25(10):695-704. doi: 10.1177/0956462414531244. Epub 2014 Apr 22. Int J STD AIDS. 2014. PMID: 24759563

9

HIV treatment strategies across Central, Eastern and Southeastern Europe: New times, old problems.

Papadopoulos A, Thomas K, Protopapas K, Antonyak S, Begovac J, Dragovic G, Gökengin D, Aimla K, Krasniqi V, Lakatos B, Mardarescu M, Matulionyte R, Mulabdic V, Oprea C, Panteleev A, Sedláček D, Sojak L, Skrzat-Klapaczyńska A, Vassilenko A, Yancheva N, Yurin O, Horban A, Kowalska JD; Euroguidelines in Central and Eastern Europe Network Group. Papadopoulos A, et al. Among authors: gokengin d. HIV Med. 2022 Oct 4. doi: 10.1111/hiv.13416. Online ahead of print. HIV Med. 2022. PMID: 36196025

10

[Should Tetanus Vaccine Booster be Given Earlier in Individuals Living with HIV?].

Nazlı A, Kenanoğlu B, Işıkgöz Taşbakan M, Pullukçu H, Zeytinoğlu A, Gökengin D. Nazlı A, et al. Among authors: gokengin d. Mikrobiyol Bul. 2022 Jan;56(1):49-58. doi: 10.5578/mb.20229905. Mikrobiyol Bul. 2022. PMID: 35088959 Free article. Turkish.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results